We are live on
!
Find out more
MC
Medici Capital Portfolio holdings
AUM
$81.2M
1-Year Est. Return
76.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.59%
1 Year Est. Return
+76.04%
3 Year Est. Return
+166.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$14.1M
(-10%)
Cap. Flow
-$51.5M
Cap. Flow
% of AUM
-41.25%
Top 10 Holdings %
Top 10 Hldgs %
95.68%
Holding
33
New
–
Increased
6
Reduced
–
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELE
Elemental Royalty Corp
ELE
|
+$12.2M |
| 2 |
ITRG
Integra Resources
ITRG
|
+$2.65M |
| 3 |
Alector
ALEC
|
+$1.81M |
| 4 |
Agnico Eagle Mines
AEM
|
+$1.61M |
| 5 |
Dakota Gold
DC
|
+$605K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMX
EMX Royalty
EMX
|
+$14.4M |
| 2 |
SA
Seabridge Gold
SA
|
+$5.35M |
| 3 |
SKE
Skeena Resources
SKE
|
+$2.24M |
| 4 |
VOXR
Vox Royalty Corp
VOXR
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 46.22% |
| 2 | Healthcare | 1.88% |
Similar funds
SPW
RTC
MWVC
QM
FPAM
BCM
FF
AGFVA
Medici Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Medici Capital held 33 positions worth $125M, down 10% from $139M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Medici Capital withdrew a net $51.5M in Q4 2025, closing 19 positions. Its most notable exit was EMX Royalty, an estimated $14.4M position sold in full.
By sector, the portfolio is most concentrated in Materials at 46% of assets, up from 43% a quarter earlier, followed by Healthcare.
Against the trend, Medici Capital added an estimated $12.2M to Elemental Royalty Corp.
- Medici Capital added most to Elemental Royalty Corp in Q4 2025, an estimated $12.2M increase.
- Medici Capital fully exited EMX Royalty in Q4 2025, selling an estimated $14.4M.
- Medici Capital's ten largest holdings make up 96% of its $125M portfolio in Q4 2025.
- Medici Capital opened 0 new positions and closed 19 in Q4 2025.
- Medici Capital's portfolio value fell 10% quarter-over-quarter to $125M.
Based on Medici Capital's 13F filing for Q4 2025, filed 17 Feb 2026.